IPO Boutique Research, Color & More Information for Subscribers
This past week six IPOs debuted, four updated terms and six new deals were filed. There were seven IPOs on the schedule to debut this week and many of them were priced to the markets satisfaction and thus performed nicely. Four of the six deals that debuted priced within its initial range. The success this[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Virtu Financial, Inc. Symbol: VIRT Price: Last trade $23.10 Trade Date: 11/13 Shares: 6.5 million Underwriter(s) Goldman Sachs Rating=Subscription Needed Company:[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Shell Midstream Partners, L.P. Symbol: SHLX Price: Last trade $33.55 Trade Date: 11/12 Shares: 8 million Underwriter(s) Barclays Rating=Subscription Needed
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Premier, Inc. Symbol: PINC Price: Last trade $35.73 Trade Date: 11/11 Shares: 4.03 million Underwriter(s) BofA Merrill Lynch, J.P. Morgan, Wells[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Controladora Vuela Compania de Aviacion, S.A.B. de C.V. Symbol: VLRS Price: Last trade $17.36 Trade Date: 11/10 Shares: 9 million Underwriter(s)[…]
This past week zero IPOs debuted, ten updated terms and two new deals were filed. There were two IPOs on the schedule to debut this week, however, neither had the demand needed to successfully come to market. According to the underwriter, the Xtera Communications (Nasdaq: XCOM) deal has been pushed to next week. Please refer[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Wednesday, November 11 Advanced Accelerated Applications (Nasdaq: AAAP) Equity Bancshares (Nasdaq: EQBK) Voyager Therapeutics (Nasdaq: VYGR) Wave Life Sciences (Nasdaq: WVE) Friday, November 11[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Marinus Pharmaceuticals Symbol: MRNS Price: Last trade $7.73 Trade Date: 11/6 Shares: 3.9 million Underwriter(s) Jefferies, RBC Capital Markets Rating=Subscription Needed[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: HC2 Holdings, Inc. Symbol: HCHC Price: Last trade $7.63 Trade Date: 11/4 Shares: 6.6 million Underwriter(s) Jefferies Rating=Subscription Needed Company: Booz[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Education Realty Trust Symbol: EDR Price: Last trade $35.91 Trade Date: 11/3 Shares: 6.5 million Underwriter(s) BofA Merrill Lynch, KeyBanc Capital[…]
The IPO market showed signs of life with 18 deals coming to market. However, slightly less than half of these deals were healthcare related (8 of 18) and many of the deals in October saw the buy-side firmly in control as 13 of the deals were priced below their initial intended ranges, respectively. In October[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Tuesday, November 3 Fuling Global (NASDAQ: FORK) Thursday, November 5 Xtera Communication (Nasdaq: XCOM) Friday, November 6 Gensight Biologics (Nasdaq: GNST)
This past week two IPOs debuted, three updated terms and zero new deals were filed. Both IPOs that debuted this week came to market successfully but only after needing a severe price reduction. MyoKardia (Nasdaq: MYOK) priced its deal at $10.00—a whopping $5.00 below the initial $15-$17 range. The deal opened with a $1.08 premium[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Kura Oncology Symbol: KURA Price: Last trade $16.00 Description: Their common stock is quoted on the OTCQB under the symbol “KURO”[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: CoreSite Realty Corporation Symbol: COR Price: Last trade $56.62 Trade Date: 10/29 Shares: 4 million Underwriter(s) Citgroup, Jefferies Rating=Subscription Needed
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Del Taco Restaurants, Inc. Symbol: TACO Price: Last trade $12.76 Trade Date: 10/27 Shares: 3.37 million Underwriter(s) Citigroup, Piper Jaffray Rating=Subscription[…]
This past week four IPOs debuted, one updated terms and ten new deals were filed. The week’s high profile deal, Ferrari N.V. (NYSE: RACE), was the only IPO of the four at opening to debut this week- that did not disappoint. Ferrari priced a full size deal at the high end of the range, $52,[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Vital Therapies Symbol: VTL Price: Last trade $5.51 Trade Date: 10/23 Shares: 5.4 million Underwriter(s) BofA Merrill Lynch Rating=Subscription Needed
This past week one IPO debuted, three updated terms and fourteen new deals were filed. Of the four deals that were on the schedule to come to market this week, only one IPO made its debut. This demonstrates the current lack of appetite for new issues in the marketplace. The deal that came to market, First Data Corporation (NYSE: FDC),[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Tuesday, October 20 American Farmland Company (NYSE: AFCO) Wednesday, October 21 Ferrari (NYSE: RACE) Thursday, October 22 Dimension Therapeutics (Nasdaq: DMTX) Multi Packaging Solutions[…]